Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients

ClinicalTrials.gov ID: NCT02542631

Public ClinicalTrials.gov record NCT02542631. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 10:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Mellitus Patients Not Achieving Glycemic Targets on Basal Insulin With/Without Anti-Hyperglycemic Agents

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare glycemic control and treatment satisfaction using a novel bolus insulin patch (Finesse) versus a pen for initiating and managing bolus insulin dosing in patients with T2DM not achieving glycemic targets on basal insulin with/without anti-hyperglycemic agents.

Study identification

NCT ID
NCT02542631
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Calibra Medical, Inc.
Industry
Enrollment
278 participants

Conditions and interventions

Eligibility (public fields only)

Age range
22 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 1, 2015 (Actual)
Primary completion
Aug 31, 2017 (Actual)
Completion
Aug 31, 2017 (Actual)
Last update posted
Feb 4, 2025

2015 – 2017

United States locations

U.S. sites
35
U.S. states
19
U.S. cities
31
Facility City State ZIP Site status
Central Phoenix Medical Clinic Phoenix Arizona 85020 —
Advanced Metabolic Care & Research Institute, Inc. (AMCR) Escondido California 92025 —
Marin Endocrine Care and Research Greenbrae California 94904 —
National Research Institute - Wilshire Los Angeles California 90057 —
Diabetes Research Institute Mills-Peninsula Health Service San Mateo California 94401 —
Encompass Clinical Research Spring Valley California 91978 —
Denver VA Medical Center Denver Colorado 80220 —
Atlanta Diabetes Associates Atlanta Georgia 30318 —
Columbus Regional Research Institute Columbus Georgia 31904 —
Physicians Research Associates Lawrenceville Georgia 30046 —
Endocrine Research Solutions, Inc Roswell Georgia 30076 —
Rocky Mountain Diabetes and Osteoporosis Center PA Idaho Falls Idaho 83404 —
Northwestern University The Feinberg School of Medicine Chicago Illinois 60611 —
John H. Stroger, Jr. Hospital of Cook County Diabetes Center Chicago Illinois 60612 —
Iowa Diabetes and Endocrinology Research Center Des Moines Iowa 50314 —
Cotton-O'Neil Clinical Research Center Topeka Kansas 66606 —
Great Plains Diabetes Wichita Kansas 67212 —
Kentucky Diabetes Endocrinology Center Lexington Kentucky 40503 —
Medstar Health Research Institute Hyattsville Maryland 20782 —
Henry Ford Health System Detroit Michigan 48202 —
Park Nicollet Institute International Diabetes Center Minneapolis Minnesota 55416 —
SUNY Upstate Medical University Syracuse New York 13210 —
VA Medical Center Cleveland Cleveland Ohio 44106 —
University Diabetes and Endocrine Consultants Chattanooga Tennessee 37411 —
Texas Diabetes & Endocrinology, P.A.- Austin Austin Texas 78749 —
Dallas Diabetes and Endocrine Center Dallas Texas 75230 —
Baylor Endocrine Center Dallas Texas 75246 —
Diabetes & Glandular Disease Clinic, P.A. San Antonio Texas 78229 —
South Texas Veterans Health Care System San Antonio Texas 78229 —
Consano Clinical Research San Antonio Texas 78258 —
Progressive Clinical Research Bountiful Utah 84010 —
Highland Clinical Research Salt Lake City Utah 84124 —
Danville Internal Medicine Danville Virginia 24541 —
Private Practice-Larry Stonesifer Federal Way Washington 98003 —
Rainier Clinical Research Center Renton Washington 98057 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02542631, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 4, 2025 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02542631 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →